Role of nitric oxide in angiotensin IV-induced increases in cerebral blood flow

Regulatory Peptides

Volumn 74, Issue 2-3, 1998, Pages 185-192

  Kramár, Enikö A ^a   Krishnan, Radhika ^a   Harding, Joseph W ^a   Wright, John W ^a  

^a Program in Neuroscience   (United States)

Author keywords

Cerebral microcirculation; Laser Doppler flowmetry; Lysine1 AngIV; Norleucinal; Norleucine1 AngIV; Rats

Indexed keywords

ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II [3-8]; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORLEUCINAL; NORLEUCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; DRUG EFFECT; INTRAARTERIAL DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC CIRCULATION; VASODILATATION;

ANGIOTENSIN II; ANIMALS; BRAIN; ENZYME INHIBITORS; FEMALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031837628     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(98)00039-1     Document Type: Article

References (46)

1. Cummings JL, Tomiyasu U, Read S, Benson DF Amnesia with hippocampal lesions after cardiopulmonary arrest. Neurology. 34:1984;679-681.
2. Petito CK, Feldmann E, Pulsinelli WA, Plum F Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology. 37:1987;1281-1286.
3. Schmidt-Kastner R, Freund TF Selective vulnerability of the hippocampus in brain ischemia. Neuroscience. 40:1991;599-636.
4. Volpe BT, Hirst W The characterization of an amnesic syndrome following hypoxic ischemic injury. Arch Neurol. 40:1983;436-440.
5. Jarrard LE On the role of the hippocampus in learning and memory in the rat. Behav Neural Bio. 60:1993;9-26.
6. Morris RGM, Garrud P, Rawlins JNP, O'Keefe J Place navigation impaired in rats with hippocampal lesions. Nature. 297:1982;681-683.
7. Morris RGM, Schenk F, Tweedie F, Jarrard LE Ibotenate lesions of hippocampus and/or subiculum: dissociating components of allocentric spatial learning. Eur J Neurosci. 2:1990;1016-1028.
8. Sutherland RJ, Whishaw IQ, Kolb B A behavioral analysis of spatial localization following electrolytic, kainate- or colchincine-induced damage to the hippocampal formation in the rat. Behav Brain Res. 7:1983;133-153.
9. 3-4 lesions impair formation of a place learning-set in the rat and induce reflex epilepsy. Behav Brain Res. 24:1987;59-72.
10. Zola-Morgan S, Squire LR, Amaral DG Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci. 6:1986;2950-2967.
11. Ball MJ, Hachinski V, Fax A, Kirshen A A new definition of Alzheimer's disease: a hippocampal dementia. Lancet. 1:1985;14-16.
12. Vijayan V, Geddes J, Anderson K, Chang H, Ellis W, Cotman C Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation. Exp Neurol. 112:1991;72-78.
13. de la Torre JC Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci Biobehav Rev. 18:1994;397-401.
14. Paulson OB, Waldemar G Role of the local renin-angiotensin system in the autoregulation of the cerebral circulation. Blood Vessels. 28:1991;231-235.
15. 2 receptors regulate cerebral blood flow in rats. NeuroReport. 3:1992;703-704.
16. 2 receptor ligands modulate the upper limit of cerebral blood flow autoregulation in rats. J Cereb Blood Flow Metab. 13:1993;298-303.
17. Haberl RL, Decker PJ, Einhäupl KM Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. Circ Res. 68:1991;1621-1627.
18. Haberl RL Role of angiotensin receptor subtypes in the response of rabbit brain arterioles to angiotensin. Stroke. 25:1994;1476-1480.
19. Näveri L, Strömberg C, Saavedra JM Angiotensin IV reverses the acute cerebral blood flow reduction after experimental subarachnoid hemorrhage in the rat. J Cereb Blood Flow Metab. 14:1994;1096-1099.
20. de Gasparo M, Husain A, Alexander W, Catt KJ, Chiu AT, Drew M, Goodfriend T, Harding JW, Inagami T, Timmermans PBMWM Proposed update of angiotensin receptor nomenclature. Hypertension. 25:1995;924-939.
21. Harding JW, Cook VI, Miller-Wing AV, Hanesworth JM, Sardinia MF, Hall KL, Stobb JW, Swanson GN, Coleman JK, Wright JW, Harding EC Identification of an AII (3-8) [AIV] binding site in guinea pig hippocampus. Brain Res. 583:1992;340-343.
22. Swanson GN, Hanesworth JM, Sardinia MF, Coleman JK, Wright JW, Hall KL, Miller-Wing AV, Stobb JW, Cook VI, Harding EC, Harding JW Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin for a receptor. Regul Pept. 40:1992;409-419.
23. Hall KL, Hanesworth JM, Ball AE, Felgenhauer GP, Hosick HL, Harding JW Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV. Regul Pept. 44:1993;225-232.
24. Hall KL, Venkateswaran S, Hanesworth JM, Schelling ME, Harding JW Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regul Pept. 58:1995;107-115.
25. Timmermanns PBMWM, Wong PC, Chiu AT, Herblin WF Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol Sci. 12:1991;55-62.
26. Krebs LT, Kramár EA, Hanesworth JM, Sardinia MF, Ball AE, Wright JW, Harding JW Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist. Regul Pept. 67:1996;123-130.
27. Kramár EA, Harding JW, Wright JW Angiotensin II- and IV-induced changes in cerebral blood flow: roles of AT1, AT2, and AT4 receptor subtypes. Regul Pept. 68:1997;131-138.
28. Misumi J, Gonzales MF, Ogihara T, Corvaol P, Menard J Vascular effects and metabolism of angiotensins and their metabolites in the isolated-perfused rat kidney. Clin Exp Hypertens. A5:1983;1151-1162.
29. Sardinia MF, Hanesworth JM, Krebs LT, Harding JW AT4 receptor binding characteristics: D-amino acid- and glycine-substituted peptides. Peptides. 14:1993;949-954.
30. Morikawa E, Moskowitz MA, Huang Z, Yoshida T, Irikura K, Dalkara T L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow and reduces infarction volume in the rat. Stroke. 25:1994;429-435.
31. Patel JM, Block ER Angiotensin IV-stimulated activation of nitric oxide synthase in porcine and human pulmonary artery endothelial cells. Am J Respir Crit Care Med. 155:1997;A119.
32. Sardinia MF, Hanesworth JM, Krishnan R, Harding JW AT4 receptor structure-binding relationship: N-terminal-modified angiotensin IV analogues. Peptides. 15:1994;1399-1406.
33. Møeller I, Chai SY, Oldfield BJ, McKinley MJ, Casley D, Mendelsohn FAO Localization of angiotensin IV binding sites to motor and sensory neurons in the sheep spinal cord and hindbrain. Brain Res. 701:1995;301-306.
34. Wright HW, Krebs LT, Stobb JW, Harding JW The angiotensin IV system: functional implications. Front Neuroendocrinol. 16:1995;23-52.
35. Wright J.W., Harding J.W. Important roles for angiotensin III and IV in the brain renin-angiotensin system. Brain Res Rev. 25:1997;96-124.
36. Wright JW, Miller-Wing AV, Shaffer MJ, Higginson C, Wright DE, Hanesworth JM, Harding JW Angiotensin II(3-8) [Ang IV] hippocampal binding: potential role in the facilitation of memory. Brain Res Bull. 32:1993;497-502.
37. Wright JW, Clemens JA, Panetta JA, Smalstig EB, Stubley-Weatherly L, Kramár EA, Pederson ES, Mungall BH, Harding JW Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats. Brain Res. 717:1996;1-11.
38. Coleman JK, Ong B, Sardinia M, Harding JW, Wright JW Changes in renal blood flow due to infusions of angiotensin II (3-8) [AIV] in normotensive rats. FASEB J. 6:1992;A981.
39. Naveri L. The roles of angiotensin receptor subtypes in cerebrovascular regulation in the rat. Acta Physiol Scand. 155(Suppl. 630):1995;2-48.
40. Yoshida M, Kikukawa M, Hisa H, Satoh S Modulation by nitric oxide and prostaglandin of the renal vascular response to angiotensin II (3-8). Br J Pharmacol. 117:1996;885-890.
41. Møeller I, Small DH, Reed G, Harding JW, Mendelsohn FA, Chai SY Angiotensin IV inhibits neurite outgrowth in cultured embryonic chicken sympathetic neurones. Brain Res. 726:1996;61-66.
42. 4 receptor system in the rat kidney. Am J Physiol. 274:1998;F290-F299.
43. 1]-angiotensinIV reduces mechanically induced immediate-early glial expression in isolated rabbit heart. Regul Pept. 71:1997;175-183.
44. Kerins DM, Hao Q, Vaughan DE Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest. 96:1995;2515-2520.
45. Coleman J.K.M., Krebs L.T., Hamilton T.A., Ong B., Lawrence K.A., Sardinia M.F., Harding J.W., Wright J.W. Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats. Peptides. 19:1998;269-277.
46. Palmer RMJ, Ferrige AG, Moncada S Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.